跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,337 条关于
“Hypoplastic left heart syndrome”
全部
49,337
临床试验
42,468
药物
384
机构
109
资讯
6,376
7年前
FDA Grants RMAT Designation To Mesoblast's Revascor for Pediatric Hypoplastic Left Heart Syndrome
昨天
Longeveron's Laromestrocel Misses Primary Endpoint in ELPIS II Phase 2b Trial in Hypoplastic Left Heart Syndrome
2年前
Longeveron Achieves FDA Alignment on Lomecel-B Pathway for Hypoplastic Left Heart Syndrome
去年
Longeveron's Lomecel-B Shows Promising 5-Year Transplant-Free Survival in HLHS Patients
去年
Longeveron Licenses Novel Cardiac Stem Cell Technology to Address Safety Concerns in Heart Disease Treatment
去年
Longeveron's Lomecel-B Shows Long-Term Survival Benefit in HLHS Patients
去年
Longeveron Appoints Than Powell as Chief Business Officer to Lead Alzheimer's and HLHS Program Strategy
去年
Longeveron's Lomecel-B Nears Full Enrollment in Pivotal HLHS Trial, Shows Promise in Pediatric Heart Disease
10个月前
Longeveron Secures Canadian Patent for Stem Cell Therapy Targeting Aging-Related Frailty and Heart Disease
去年
Longeveron's Lomecel-B Data in Alzheimer's Disease to be Presented at CTAD24
第 1 页，共 638 页
上一页
下一页
